Industry

BURLINGTON, Ontario–(BUSINESS WIRE)–$ELMT–Third paragraph, second sentence of the release dated July 13, 2022, should read: Rejuvenate™ Immune Health is available in 15-serve and 45-serve sizes and in an orange splash flavour. The updated release reads: ELEMENT NUTRITIONAL SCIENCES ANNOUNCES REJUVENATE™ IMMUNE HEALTH NOW AVAILABLE THROUGH AMAZON.COM Element Nutritional Sciences Inc. (CSE:ELMT; OTC:ELNSF; FRANKFURT:93X) (the “Company” … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Thrombosis Drug Market Research Report by Drug Class (Factor Xa Inhibitor, Heparin, and P2Y12 Platelet Inhibitor), Disease Type, Distribution Channel, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Thrombosis Drug Market size was … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Congenital Diarrheal Disorders – Epidemiology Forecast to 2032” report has been added to ResearchAndMarkets.com’s offering. This report delivers an in-depth understanding of the disease, historical and forecasted Congenital Diarrheal Disorders epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered The United … [Read more…]

CHELMSFORD, Mass.–(BUSINESS WIRE)–ZOLL® Medical Corporation, an Asahi Kasei company that manufactures medical devices and related software solutions, announced today that the Centers for Medicare & Medicaid Services (CMS) ICD-10 Coordination and Maintenance Committee has issued a new ICD-10-PCS code for TherOx® SuperSaturated Oxygen (SSO2) Therapy. The new code (5A0222C), for cardiac intra-arterial use, is effective … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “RNA Therapy Market Research Report by Technology (Enabled Technologies and Enabling Technologies), Application, End User, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) – Global Forecast to 2026 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global RNA Therapy Market size was estimated at USD 1,328.36 million … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Psoriasis Therapeutics Market Research Report by Molecule (Biologics and Small Molecules), Route of Administration, Dosage Forms, Mechanism of Action, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Psoriasis Therapeutics Market size was estimated … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Parenteral Nutrition Market Research Report by Nutrient Type (Amino Acids, Carbohydrates, and Electrolytes), Dosage Form, End-User, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Parenteral Nutrition Market size was estimated at USD 6,529.10 … [Read more…]

Company announces completion of Phase 1 dose escalation ahead of schedule for IO-108, a first-in-class antibody targeting LILRB2 (ILT4) Signals of clinical activity observed in multiple tumor types for IO-108 as a single agent and in combination with an anti-PD-1 PALO ALTO, Calif.–(BUSINESS WIRE)–#ILT3–Immune-Onc Therapeutics, Inc. (“Immune-Onc”), a private, clinical-stage cancer immunotherapy company developing novel … [Read more…]

VIENNA, Va.–(BUSINESS WIRE)–$CVM #Multikine–CEL-SCI Corporation (NYSE American: CVM) announces that Geert Kersten, Chief Executive Officer, will be on Reddit AMA (“Ask Me Anything”) today at 12:30 PM ET to discuss Multikine and our recent publications at ASCO 2022. Come ask him anything relevant at reddit.com/r/IAmA/. About CEL-SCI Corporation CEL-SCI believes that boosting a patient’s immune … [Read more…]

ROCKVILLE, Md.–(BUSINESS WIRE)–Creative Bio-Peptides, Inc, a preclinical-stage biotechnology company developing novel therapies to balance the innate immune system and promote regeneration of damaged neurons, today announced the publication of findings from a preclinical study showing that treatment with the small oral peptide chemokine receptor antagonist RAP-103 reduced the amount of opioid needed after surgery by … [Read more…]